BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20544705)

  • 1. The GIST of a tumor's transformation.
    Nelson B
    Cancer Cytopathol; 2010 Jun; 118(3):114. PubMed ID: 20544705
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal Stromal Tumors (GIST) special issue. Preface.
    Patel SR
    Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S1. PubMed ID: 21116629
    [No Abstract]   [Full Text] [Related]  

  • 3. [A step foward in the treatment of GIST].
    Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(4):223-4. PubMed ID: 18776977
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour.
    Abdulkader I; Cameselle-Teijeiro J; Forteza J
    Histopathology; 2005 Apr; 46(4):470-2. PubMed ID: 15810964
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors?
    Wasserberg N; Nunoo-Mensah JW; Beart RW; Ker TS
    Int J Colorectal Dis; 2007 Aug; 22(8):981-2. PubMed ID: 16583196
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
    Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs].
    Shiba K; Matsumoto T; Hirota S
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1080-5. PubMed ID: 19620796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Please, desist RECIST criteria in GIST, at least in me'.
    Sevinc A; Turhal NS
    Onkologie; 2008 Oct; 31(10):556. PubMed ID: 18854657
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of GIST.
    Blanke C
    Clin Adv Hematol Oncol; 2004 May; 2(5):280, 283. PubMed ID: 17682286
    [No Abstract]   [Full Text] [Related]  

  • 11. Could imatinib replace surgery in esophageal gastrointestinal stromal tumor.
    Al-Salam S; El-Teraifi HA; Taha MS
    Saudi Med J; 2006 Aug; 27(8):1236-9. PubMed ID: 16883460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new genetic diagnosis of familiar gastrointestinal stromal tumour].
    Wadt K; Andersen MK; Hansen TV; Gerdes AM
    Ugeskr Laeger; 2012 May; 174(21):1462-4. PubMed ID: 22640790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors.
    von Mehren M; Watson JC
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):547-64, vii. PubMed ID: 15939196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment.
    Sleijfer S; Wiemer E; Verweij J
    Nat Clin Pract Oncol; 2008 Feb; 5(2):102-11. PubMed ID: 18235442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib in gastrointestinal stromal tumors.
    Bakshi CA; Jain RA; Sastry PS; Sainani AR; Advani SH
    J Assoc Physicians India; 2004 May; 52():403-9. PubMed ID: 15656032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital.
    Yeh CN; Chen TW; Lee HL; Liu YY; Chao TC; Hwang TL; Jan YY; Chen MF
    Ann Surg Oncol; 2007 Mar; 14(3):1123-8. PubMed ID: 17195905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
    Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
    Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imatinib and solid tumours].
    Arifi S; El Sayadi H; Dufresne A; Ray-Coquard I; Fayette J; Méeus P; Ranchère D; Decouvelaere AV; Alberti L; Tabone-Eglinger S; Blay JY; Cassier P
    Bull Cancer; 2008 Jan; 95(1):99-106. PubMed ID: 18230575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.